Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX)

CUSIP: 01438T106

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
59,794,743
Total 13F shares
37,181,780
Share change
+574,436
Total reported value
$185,566,183
Put/Call ratio
67%
Price per share
$4.99
Number of holders
117
Value change
+$2,534,433
Number of buys
58
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2024

As of 31 Dec 2024, Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37,181,780 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, Knoll Capital Management, LLC, BlackRock, Inc., VANGUARD GROUP INC, KENNEDY CAPITAL MANAGEMENT LLC, ARDSLEY ADVISORY PARTNERS LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, and RAYMOND JAMES FINANCIAL INC. This page lists 117 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.